Short communication · 4 Aug 2026
Conference abstractPublished 12 Sep 2016
Cost-effectiveness of DCMR guided management of patients with stable coronary artery diseasecombining data mining of the early adoption phases of new technologies with long-term outcomes
German Heart Center, Germany; CharitÃ?© University Medicine Berlin, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Dobutamine stress CMR (DCMR) is an accurate and safe non-invasive test for coronary artery disease (CAD) with high negative predictive value. Direct catheterization (CA) is still an alternative approach that is incentivized by the current reimbursement policy in many countries. Since long-term outcome and cost data from randomized controlled prospective trials are rarely available when new health technologies emerge, evidence based reimbursement policy requires retrospective data mining and lags behind medical and technical evolution. This paper presents level 5 HTA data on DCMR based on a long term follow-up of patients with suspected stable CAD (sCAD) who underwent DCMR and controls with direct CA. We expected that a DCMR guided approach would be at least as effective as direct CA with respect to survival and more patient friendly in terms of fewer hospitalizations during follow-up by avoiding direct CA. Generally, we suggest data mining digital documentation of early adoption phases of new technologies as source of evidence. This study was a single center retrospective cohort trial that compares two different pathways for managing patients with sCAD and intermediate event risk. Groups (CMR: 209 pts. CA: 293 pts) were matched by propensity scores. Clinical data were collected from institutional quality assurance and research databases. Median patient follow-up was 7.9 years. Primary clinical endpoints were death and cardiac re-hospitalizations. The cost data were calculated per patient and hospital stay from original resource utilization data provided to the German federal InEK/G-DRG database. We chose cost contribution accounting as method to compare both approaches.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical and Experimental Cardiology.
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Wellnhofer Ernst”
